ScholarIQanswers from OpenAlex

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects

PaperCitations, authors & open-access status

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects have?

ScholarIQcitation count

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects has 236 citations in the OpenAlex counts ScholarIQ stores.

When was Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects published?

ScholarIQyear

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects has 1988 year in the ScholarIQ index.

What is the open-access status of Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects?

ScholarIQoa status

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects has closed oa status in the ScholarIQ index.

What is the DOI of Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects?

ScholarIQdoi

The DOI for Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects is on the source record.

What is the PMID of Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects?

ScholarIQpmid

The PMID for Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects is on the source record.

What is the OpenAlex record for Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects?

ScholarIQopenalex

The OpenAlex for Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial